Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5022
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Karimov Mirvosit Mirvasikovich, Sobirova Guzal Naimovna, Zargarova Nargiza Rustamovna | - |
dc.date.accessioned | 2022-12-13T11:15:34Z | - |
dc.date.available | 2022-12-13T11:15:34Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 978-0-578-26510-0 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/5022 | - |
dc.description.abstract | The global and regional impact of the SARS-CoV-2 pandemic is of great concern. Although the availability of vaccines against SARS-CoV-2 has partially alleviated this concern in some parts of the world, it remains a global public health crisis. Diagnosing gut microbiota in patients after infection with COVID-19. The research was conducted on 120 (54 men and 66 women) patients aged 29 to 70 years and 20 healthy people treated for dysbacteriosis in the gastroenterology department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The composition of intestinal microorganisms in patients with dysbacteriosis is almost the same, but its quantitative ratio differs according to whether or not they have had COVID-19. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | North American Academic Publishing Platforms | en_US |
dc.relation.ispartofseries | l 10.5281/zenodo.7219791; | - |
dc.subject | SARS-CoV-2, intestinal microbiota, methods, determine | en_US |
dc.title | METHODS OF DETERMINING THE INTESTINAL MICROBIOTA IN PATIENTS AFTER COVID-19 | en_US |
dc.title.alternative | Art of Medicine International Medical Scientific Journal 10.5281/zenodo.7219791 | en_US |
dc.type | Article | en_US |
Appears in Collections: | Tashkent Medical Academy Historical Books |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
5. Art of med_2022, 172-180.pdf | The global and regional impact of the SARS-CoV-2 pandemic is of great concern. Although the availability of vaccines against SARS-CoV-2 has partially alleviated this concern in some parts of the world, it remains a global public health crisis. Diagnosing gut microbiota in patients after infection with COVID-19. The research was conducted on 120 (54 men and 66 women) patients aged 29 to 70 years and 20 healthy people treated for dysbacteriosis in the gastroenterology department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The composition of intestinal microorganisms in patients with dysbacteriosis is almost the same, but its quantitative ratio differs according to whether or not they have had COVID-19. | 427.96 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.